How AI Is Being Used in Medicare Approvals (And Why It's Controversial): Key2Medicare Helps Colorado Beneficiaries Navigate the Risks

Share this news:

Medicare Advantage plans increasingly use AI algorithms to process prior authorization requests, often denying necessary care in seconds without proper clinical review. A June 2026 federal watchdog report confirmed that 95% of appealed care denials were overturned, raising serious concerns about automated health system oversight.

-- Medicare Advantage plans now use AI to process prior authorization requests rapidly. According to KFF reports, insurers processed nearly 53 million requests in 2024, denying 4.1 million of them. Of those denied, only a fraction were appealed. Yet, when beneficiaries did challenge the decision, 80.7% were fully or partially overturned, signaling that many contested denials were likely incorrect.

The controversy lies in the appeals that never happen. Most patients accept the denial and either forgo care, pay out of pocket, or delay treatment. A June 2026 report from the U.S. Office of Inspector General found that 12% of skilled nursing facility admission requests were denied, and 95% of those denials were overturned on appeal. This pattern suggests AI-assisted systems may be systematically denying appropriate care to cut short-term costs, while beneficiaries rarely fight back.

In response to growing concern about how AI-driven authorization practices differ between Medicare Advantage plans, Key2Medicare is now incorporating prior authorization burden and plan-level denial history into its plan comparison consultations for Colorado beneficiaries. Licensed broker Jenell Sobas advises that authorization requirements are one of the most underexamined variables in Medicare Advantage plan selection, and one of the most consequential for beneficiaries who will need post-acute care, specialist services, or ongoing treatment management.

Most plan comparison tools show monthly premiums, drug formularies, and network directories. They don't show how often a plan denies prior authorization requests or how often those denials are overturned on appeal. This data exists in CMS reporting, but it requires time and expertise to interpret. Key2Medicare uses it as part of a complete consultation, helping beneficiaries understand what a plan covers on paper and how consistently it delivers that coverage in practice. For beneficiaries managing chronic conditions, this distinction can determine whether care is received on time or delayed by weeks.

Key2Medicare also explains what beneficiaries can do when a Medicare Advantage plan issues a denial. Federal rules require plans to process expedited appeals within 72 hours and standard appeals within 30 days. Beneficiaries who receive a denial have the right to request a peer-to-peer review between their physician and the plan's medical director.

The use of AI in Medicare Advantage approvals will expand as plans manage rising enrollment volumes. What changes the outcome for individual beneficiaries is knowing how a specific plan uses that technology, and having an independent advisor who can compare options before enrollment rather than after a claim has been denied. Key2Medicare is currently accepting consultation requests across Colorado at no cost to the beneficiary.

About the company: Key2Medicare is an independent Medicare advisory service based in Littleton, Colorado, specializing in Medicare Advantage, Medicare Supplement, and Part D prescription drug plans. Under the leadership of licensed independent broker Jenell Sobas, the agency offers one-on-one support to help Medicare beneficiaries choose coverage that fits their needs, with no fees charged to clients.

Contact Info:
Name: Jenell Sobas
Email: Send Email
Organization: Key 2 Medicare Insurance
Website: https://key2medicare.com/

Release ID: 89200011

CONTACT ISSUER
Name: Jenell Sobas
Email: Send Email
Organization: Key 2 Medicare Insurance
REVIEWED BY
Editor Profile Picture
This content is reviewed by our News Editor, Hui Wong.

If you need any help with this piece of content, please contact us through our contact form
SUBSCRIBE FOR MORE